Havens discusses cannabis regulation and impact on FDA during FDLI webinar

Havens discusses cannabis regulation and impact on FDA during FDLI webinar
Regulation of Cannabis in FDA-Regulated Products
July 19, 2017

Jonathan Havens, an associate in Saul Ewing’s Food and Beverage Practice, discusses the current state of cannabis regulation for medical and recreational use and the impact on FDA-related products in this webinar presented by the Food and Drug Law Institute. In addition, the webinar will also explain clinical research being conducted for INDs and NDAs, as well as issues related to edibles and dietary supplements, such as good manufacturing practices.

For more information, including registration details, click here.

Blog Entries